Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference39 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018
2. Reducing lung cancer and other tobacco-related cancers in Europe: smoking cessation is the key;Clancy;Oncologist,2014
3. AJRCCM: 100-year anniversary. The shifting landscape for lung cancer: past, present, and future;Vachani;Am. J. Respir. Crit. Care Med.,2017
4. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015
5. Survival in patients with metachronous second primary lung cancer;Ha;Ann. Am. Thorac. Soc.,2015
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MicroRNA in lung cancer—a novel potential way for early diagnosis and therapy;Journal of Applied Genetics;2023-02-23
2. Non-Coding RNAs in Airway Diseases: A Brief Overview of Recent Data;Cancers;2022-12-22
3. LncRNA H19 Promotes Lung Adenocarcinoma Progression via Binding to Mutant p53 R175H;Cancers;2022-09-16
4. From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer;Cells;2022-09-07
5. Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis;Frontiers in Molecular Biosciences;2022-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3